Afficher la notice abrégée

dc.rights.licenseopenen_US
hal.structure.identifierBiologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases
dc.contributor.authorCARADU, Caroline
hal.structure.identifierBiologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases
dc.contributor.authorCOUFFINHAL, Thierry
hal.structure.identifierBiologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases
dc.contributor.authorCHAPOULY, Candice
hal.structure.identifierBiologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases
dc.contributor.authorGUIMBAL, Sarah
hal.structure.identifierBiologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases
dc.contributor.authorHOLLIER, Pierre-Louis
hal.structure.identifierBiologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases
dc.contributor.authorDUCASSE, Eric
dc.contributor.authorBURA-RIVIÈRE, Alessandra
dc.contributor.authorDUBOIS, Mathilde
hal.structure.identifierBiologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases
dc.contributor.authorGADEAU, Alain-Pierre
hal.structure.identifierBiologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases
dc.contributor.authorRENAULT, Marie-Ange
dc.date.accessioned2020
dc.date.available2020
dc.date.issued2018
dc.identifier.issn1524-4571en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/20882
dc.description.abstractEnRATIONALE: Klf (kruppel-like factor) 2 is critical to establish and maintain endothelial integrity. OBJECTIVE: Therefore, determining upstream and downstream mediators of Klf2 would lead to alternative therapeutic targets in cardiovascular disease management. METHODS AND RESULTS: Here we identify Dhh (desert hedgehog) as a downstream effector of Klf2, whose expression in endothelial cells (ECs) is upregulated by shear stress and decreased by inflammatory cytokines. Consequently, we show that Dhh knockdown in ECs promotes endothelial permeability and EC activation and that Dhh agonist prevents TNF-α (tumor necrosis factor alpha) or glucose-induced EC dysfunction. Moreover, we demonstrate that human critical limb ischemia, a pathological condition linked to diabetes mellitus and inflammation, is associated to major EC dysfunction. By recreating a complex model of critical limb ischemia in diabetic mice, we found that Dhh-signaling agonist significantly improved EC function without promoting angiogenesis, which subsequently improved muscle perfusion. CONCLUSION: Restoring EC function leads to significant critical limb ischemia recovery. Dhh appears to be a promising target, downstream of Klf2, to prevent the endothelial dysfunction involved in ischemic vascular diseases.
dc.language.isoENen_US
dc.subjectArticle RECHERCHE
dc.subject.enAnimal
dc.subject.enAnimals
dc.subject.enAutocrine Communication
dc.subject.enCapillary Permeability
dc.subject.enCells
dc.subject.enCritical Illness
dc.subject.enCultured
dc.subject.enCyclohexylamines
dc.subject.enCytokines
dc.subject.enDisease Models
dc.subject.enEndothelial cells
dc.subject.enEndothelial Cells
dc.subject.enGene Expression Regulation
dc.subject.enHedgehog Proteins
dc.subject.enhedgehogs
dc.subject.enHindlimb
dc.subject.enHuman Umbilical Vein Endothelial Cells
dc.subject.enHumans
dc.subject.enInbred C57BL
dc.subject.eninflammation
dc.subject.enInflammation Mediators
dc.subject.enIschemia
dc.subject.enKnockout
dc.subject.enKruppel-Like Transcription Factors
dc.subject.enMale
dc.subject.enMechanical
dc.subject.enMice
dc.subject.enMuscle
dc.subject.enNeovascularization
dc.subject.enperipheral arterial disease
dc.subject.enPhysiologic
dc.subject.enRegional Blood Flow
dc.subject.enSignal Transduction
dc.subject.enSkeletal
dc.subject.enStress
dc.subject.entherapeutics
dc.subject.enThiophenes
dc.title.enRestoring Endothelial Function by Targeting Desert Hedgehog Downstream of Klf2 Improves Critical Limb Ischemia in Adults
dc.typeArticle de revueen_US
dc.identifier.doi10.1161/CIRCRESAHA.118.313177en_US
dc.subject.halSciences du Vivant [q-bio]/Médecine humaine et pathologieen_US
dc.identifier.pubmed30355159en_US
bordeaux.journalCirculation Researchen_US
bordeaux.page1053–1065en_US
bordeaux.volume123en_US
bordeaux.hal.laboratoriesBiologie des maladies cardiovasculaires - U1034en_US
bordeaux.issue9en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.exportfalse
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Circulation%20Research&rft.date=2018&rft.volume=123&rft.issue=9&rft.spage=1053%E2%80%931065&rft.epage=1053%E2%80%931065&rft.eissn=1524-4571&rft.issn=1524-4571&rft.au=CARADU,%20Caroline&COUFFINHAL,%20Thierry&CHAPOULY,%20Candice&GUIMBAL,%20Sarah&HOLLIER,%20Pierre-Louis&rft.genre=article


Fichier(s) constituant ce document

Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée